DNAlytics

DNAlytics, founded in 2012 and headquartered in Belgium, is at the forefront of leveraging data analytics to revolutionize the biotechnology and data analytics sectors. With the slogan "Data-driven healthcare," the company is dedicated to accelerating the development and deployment of healthcare solutions through innovative data-driven strategies.

In a field plagued by inefficient diagnostic and therapeutic strategies, DNAlytics positions itself as a solution provider blending Data Science and traditional consulting to create decision-support tools, utilizing Machine Learning, Artificial Intelligence, and Cloud Computing. Their services span clinical development, R&D, and patient care optimization, showing consistent two-digit growth in turnover annually since inception.

The company's machine learning library, LiblineaR, is globally downloaded over 2,000 times monthly, and their platform, rheumakit.com, serves more than 40,000 users per year worldwide. Notably, over half of their revenue is generated outside Belgium, a part from outside the EU. Their last reported funding was a €50,000 grant from the EASME - EU Executive Agency for SMEs in April 2015. This investor support, combined with DNAlytics' traction and strategic growth, makes it a compelling prospect for further investment.